Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy

医学 雷米普利 射血分数 心脏病学 内科学 心肌梗塞 缬沙坦 沙库比林、缬沙坦 沙库比林 心力衰竭 血管紧张素转换酶抑制剂 血管紧张素转换酶 血压
作者
Amil M. Shah,Brian Claggett,Narayana Prasad,Guichu Li,Mayra Volquez,Karola Jering,Maja Čikeš,Attila Kovács,Wilfried Mullens,José Carlos Nicolau,Lars Køber,Peter van der Meer,Pardeep S. Jhund,Ghionul Ibram,Martin Lefkowitz,Yinong Zhou,Scott D. Solomon,Marc A. Pfeffer
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:146 (14): 1067-1081 被引量:30
标识
DOI:10.1161/circulationaha.122.059210
摘要

Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV) enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits with combined angiotensin receptor neprilysin inhibition, but human data are conflicting. The PARADISE-MI Echo Study (Prospective ARNI Versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After Myocardial Infarction) tested the effect of sacubitril/valsartan compared with ramipril on LV function and adverse remodeling after high risk-AMI. Methods: In a prespecified substudy, 544 PARADISE-MI participants were enrolled in the Echo Study to undergo protocol echocardiography at randomization and after 8 months. Patients were randomized within 0.5 to 7 days of presentation with their index AMI to receive a target dose of sacubitril/valsartan 200 mg or ramipril 5 mg twice daily. Echocardiographic measures were performed at a core laboratory by investigators blinded to treatment assignment. The effect of treatment on change in echo measures was assessed with ANCOVA with adjustment for baseline value and enrollment region. The primary end points were change in LV ejection fraction (LVEF) and left atrial volume (LAV), and prespecified secondary end points included changes in LV end-diastolic and end-systolic volumes. Results: Mean age was 64±12 years; 26% were women; mean LVEF was 42±12%; and LAV was 49±17 mL. Of 544 enrolled patients, 457 (84%) had a follow-up echo at 8 months (228 taking sacubitril/valsartan, 229 taking ramipril). There was no significant difference in change in LVEF ( P =0.79) or LAV ( P =0.62) by treatment group. Patients randomized to sacubitril/valsartan demonstrated less increase in LV end-diastolic volume ( P =0.025) and greater decline in LV mass index ( P =0.037), increase in tissue Doppler e’ lat ( P =0.005), decrease in E/e’ lat ( P =0.045), and decrease in tricuspid regurgitation peak velocity ( P =0.024) than patients randomized to ramipril. These differences remained significant after adjustment for differences in baseline characteristics. Baseline LVEF, LV end-diastolic volume, LV end-systolic volume, LV mass index, LAV, and Doppler-based diastolic indices were associated with risk of cardiovascular death or incident heart failure. Conclusions: Treatment with sacubitril/valsartan compared with ramipril after AMI did not result in changes in LVEF or LAV at 8 months. Patients randomized to sacubitril/valsartan had less LV enlargement and greater improvement in filling pressure. Measures of LV size, systolic function, and diastolic properties were predictive of cardiovascular death and incident heart failure after AMI in this contemporary, well-treated cohort. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02924727.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈冲完成签到,获得积分10
1秒前
星星的梦完成签到,获得积分10
1秒前
高高菠萝完成签到 ,获得积分10
2秒前
xiaostou完成签到,获得积分10
2秒前
赶紧毕业完成签到,获得积分10
2秒前
任婷完成签到,获得积分10
3秒前
3秒前
ForComposites完成签到,获得积分10
4秒前
鲸鱼打滚完成签到,获得积分10
4秒前
妮妮完成签到 ,获得积分10
4秒前
Jessica发布了新的文献求助10
4秒前
细嗅蔷薇完成签到,获得积分10
4秒前
5秒前
量子星尘发布了新的文献求助10
5秒前
冷艳宛白发布了新的文献求助10
6秒前
jidou1011完成签到,获得积分10
6秒前
执意完成签到 ,获得积分10
8秒前
稳重紫蓝完成签到 ,获得积分10
8秒前
moonlight完成签到,获得积分10
9秒前
云轩发布了新的文献求助10
9秒前
神内打工人完成签到 ,获得积分10
9秒前
悲凉的胡萝卜完成签到 ,获得积分10
10秒前
静心完成签到,获得积分10
11秒前
11秒前
xiaochuan完成签到,获得积分10
12秒前
月亮快打烊吖完成签到 ,获得积分10
12秒前
安之完成签到,获得积分10
13秒前
柒柒球完成签到,获得积分10
14秒前
Yolo完成签到 ,获得积分10
15秒前
15秒前
CL完成签到,获得积分10
20秒前
叶子完成签到,获得积分10
20秒前
李爱国应助Jessica采纳,获得10
22秒前
xshzhou完成签到,获得积分10
23秒前
锌小子完成签到,获得积分10
24秒前
青青完成签到,获得积分10
24秒前
士多啤梨完成签到,获得积分10
25秒前
斑马完成签到,获得积分10
26秒前
研友_85YNe8完成签到,获得积分10
27秒前
D调的华丽完成签到,获得积分10
28秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976768
求助须知:如何正确求助?哪些是违规求助? 3520874
关于积分的说明 11205018
捐赠科研通 3257788
什么是DOI,文献DOI怎么找? 1798842
邀请新用户注册赠送积分活动 877927
科研通“疑难数据库(出版商)”最低求助积分说明 806694